Managing infected seroma post-lymphadenectomy; A retrospective cohort study and cost analysis in melanoma patients

J Plast Reconstr Aesthet Surg. 2021 Sep;74(9):2251-2257. doi: 10.1016/j.bjps.2020.12.080. Epub 2021 Jan 9.

Abstract

Background and purpose: Seromas are a common and unavoidable complication following lymphadenectomy, and often become clinically significant with superseded infection requiring re-admission for prompt intervention. However, there is no consensus as to whether a formal surgical incision and drainage (I&D), ultrasound (US)-guided aspiration or intravenous (IV) antibiotics alone is the most efficacious method of managing an infected seroma, the investigation of which formed the rationale for this study.

Subjects and methods: This retrospective cohort study included a consecutive series of patients readmitted for infected seroma following a lymphadenectomy for melanoma at Leeds Teaching Hospitals Trust (LTHT) from 2006 to 2017. Details on management, length of hospital stay, length of follow-up and number of clinical appointments required were examined.

Findings: Seventy-one cases of infected seroma were identified from the cohort of 1691 lymphadenectomies. Initially, 21 patients (29.5%) were managed by IV antibiotics alone (failure rate of 52.4%); 18 (25.4%) with US-guided aspiration (failure rate 27.8%) and 32 (45.1%) with surgical I&D, which was 100% effective. Ultimately, 62.5% of the cohort required surgical management. Patients who underwent surgical I&D were discharged significantly faster following the procedure (3 versus 5 days for US-guided aspiration, p = 0.002) and spent fewer days in hospital overall (p = 0.022). The overall average cost was comparable across the three treatment groups.

Conclusions: Surgical management seemed preferential to conservative approaches in terms of efficacy and was not significantly more expensive overall; but carries anaesthetic risk. There may be a clinically significant difference in outcome depending on management; however, more evidence is required to investigate this.

Keywords: Infected seroma; Lymphadenectomy; Lymphocele; Seroma.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Female
  • Humans
  • Length of Stay / statistics & numerical data
  • Lymph Node Excision*
  • Lymphatic Metastasis / pathology*
  • Male
  • Melanoma / pathology*
  • Middle Aged
  • Postoperative Complications / microbiology*
  • Postoperative Complications / surgery*
  • Retrospective Studies
  • Seroma / microbiology*
  • Seroma / therapy*
  • Skin Neoplasms / pathology*

Substances

  • Anti-Bacterial Agents